Is AI Failing Drug Development? The Unseen Challenges
Noam Solomon, CEO at Immunai
For over a decade, we’ve heard about AI’s transformative potential in therapeutics (Tx), but where’s the evidence? Has it all been hype? Can AI still revolutionize Tx? Or is there…
Continue Reading